Abiopharma

📋 Roberts Evan (Officer) plans to sell 6K shares of Phreesia, Inc. (at $17.01 each, total $107K) Filed: Jan 08, 2026 | ID: 000226

Novel Inspiration International Co., Ltd. 🟢 acquired 97.6K shares of IRIDEX CORP (IRIX) Transaction Date: Oct 01, 2025 | Filing ID: 000010

📋 OConnell Daniel Joseph (Officer) plans to sell 8K shares of Acumen Pharmaceuticals, Inc. (at $1.82 each, total $15K) Filed: Jan 08, 2026 | ID: 000023

Illumina, Inc. - Illumina Appoints Dr. Eric Green as Chief Medical Officer

Novel Inspiration International Co., Ltd. 🟢 acquired 137.3K shares of IRIDEX CORP (IRIX) Transaction Date: Jul 01, 2025 | Filing ID: 000009

New Form 3 - IRIDEX CORP Filed: 2026-01-08 AccNo: 0002097627-26-000008 Size: 8 KB

New Form SCHEDULE 13D/A - Mersana Therapeutics, Inc. Filed: 2026-01-08 AccNo: 0001193125-26-007752 Size: 11 KB

Cavalier Jason 🔴 sold 769 shares of Lyra Therapeutics, Inc. (LYRA) at $3.36 Transaction Date: Jan 06, 2026 | Filing ID: 007760

Palasis Maria 🔴 sold 1.7K shares of Lyra Therapeutics, Inc. (LYRA) at $3.36 Transaction Date: Jan 06, 2026 | Filing ID: 007751

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Cellectis Announces 2026 Strategy and Catalysts

📋 Almstead Zheng Yang (Member of immediate family of any of the foregoing) plans to sell 59 shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $5K) Filed: Jan 08, 2026 | ID: 000225

New Form SCHEDULE 13D - IRIDEX CORP Filed: 2026-01-08 AccNo: 0002097627-26-000007 Size: 20 KB